British Association for Cytopathology October 2025 Case Study
Hodgkin Lymphoma in EBUS
Giulio R. Romani, Histopathology Trainee, Royal Cornwall Hospital Trust -Truro
Clinical Information
- 68 year old female, PMHx of HTN, hypercholesterolaemia and hypothyroidism, on HRT, active smoker. No FHx of lung cancer.
- LDCT chest July 2023 under Lung Cancer Screening program. Incidental finding of 22 x 21 mm left suprahilar mass, plan for repeat LDCT in 24 months as “AI detected nodule is measured to include an adjacent vessel, not size significant therefore dismissed”.
- Quits smoking.
- LDCT chest June 2025 shows 3.5 cm LUL ground-glass nodule with a 5 mm solid component (plan for repeat LDCT chest in 3 months as per protocol); and minor increase in size of left suprahilar mass: 2.7 cm with impression of branching vessels, possible pulmonary artery aneurysm or pseudoaneurysm, recommend CTPA to further evaluate.
